{"id":1066,"date":"2022-04-12T14:14:03","date_gmt":"2022-04-12T14:14:03","guid":{"rendered":"https:\/\/lykan.dsstaging2.com\/?post_type=team&p=1066"},"modified":"2022-05-13T14:45:51","modified_gmt":"2022-05-13T14:45:51","slug":"anthony-rotunno-lykan","status":"publish","type":"team","link":"https:\/\/ms.ragersoul.com\/lykan\/team\/anthony-rotunno-lykan\/","title":{"rendered":"Anthony Rotunno"},"content":{"rendered":"<\/a>
\r\n
\r\n
\r\n
\r\n
\r\n \"cell\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
\r\n
\r\n
\r\n \"cell\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n \r\n \t\t\t\t\t\r\n
\r\n\r\n
\r\n \r\n\t\t\t\t\t\t\t\t\t\t\t\t \r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t \r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t \r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t \"doctor\r\n <\/picture>\r\n <\/div>\r\n\r\n
\r\n\r\n \r\n
\r\n\r\n\t\r\n
\r\n
\r\n\t\t\t
\r\n\r\n
\r\n\t\t\t\t\t\t\t\t\t\t

Anthony Rotunno – Lykan Bioscience<\/h1>\t\t\t\r\n\t\t\t <\/div>\r\n\r\n\t\t <\/div>\r\n\t\t\t <\/div>\r\n <\/div>\r\n\r\n\r\n<\/div>\r\n <\/div>\r\n <\/div>\r\n\r\n<\/div>\r\n\n\n<\/a>
\r\n
\r\n
\r\n\r\n
\r\n
\r\n \"cell\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n \r\n\t\t\t\t\t\t\r\n
\r\n \n<\/a>\r\n
\r\n\r\n \t\t\t\t\t\r\n
\r\n
\r\n\r\n\t\r\n
\r\n
\r\n
\r\n\r\n\t\t\t\r\n\t\t\t\r\n
\r\n\r\n
\r\n Founder and Executive Vice Chairman <\/div>\r\n \r\n

Anthony Rotunno<\/h1> \r\n <\/div>\r\n
\r\n

As a founding member of Lykan Bioscience, Tony aims to revolutionize the Cell Therapy industry by bringing his expertise in value creation to Lykan\u2019s full range of development and manufacturing services for cell-based therapies.<\/p>\n <\/div>\r\n\r\n\t\t\t\t\t\t\t

\r\n\t\t\t\t\tView linkedin profile<\/span><\/use><\/svg><\/span><\/a>\r\n\t\t <\/div>\r\n\t <\/div>\r\n <\/div>\r\n\r\n
\r\n\t\t\r\n\r\n
\r\n \r\n \r\n \r\n \r\n
\r\n \"Photo\r\n <\/div>\r\n \r\n \r\n <\/div>\r\n\r\n\t\t <\/div>\r\n<\/div>\r\n\r\n<\/div>\r\n <\/div>\r\n\r\n \r\n<\/div>\r\n\n\n<\/a>\r\n
\r\n\r\n \t\t\t\t\t\r\n
\r\n \r\n
\r\n\r\n\t
\r\n

A seasoned industry veteran with more than 40 years of biologics manufacturing experience,\u00a0 Tony\u2019s successes include turning top-heavy, inefficient operations into profitable organizations as well as multiple plant builds and successful acquisitions. His experience spans both biopharmaceutical and contract manufacturing organizations including WelGen, Pharmachem, Dendreon, Lonza\/Cambrex, and Marathon Biopharmaceuticals.<\/p>\n

While at Dendreon (2010), Mr. Rotunno was instrumental in recreating Dendreon\u2019s Provenge\u00ae operations which included the startup, commissioning, and validation of two new facilities and reducing cost of goods by approximately 80% over a 5-year period.<\/p>\n

At Marathon, Tony guided the team in launching the manufacturing operations for the first genetically engineered recombinant \/transgenic antithrombin (ATryn\u2122) moving the company from net losses to the production of multiple generations of biologics and generating $100 million in revenue.<\/p>\n <\/div>\r\n\r\n\r\n\t\r\n<\/div>\r\n <\/div>\r\n\r\n \r\n<\/div>\r\n\n\r\n <\/div>\r\n<\/div>\r\n\n\n<\/a>\r\n

\r\n\r\n \t\t\t\t\t\r\n
\r\n \r\n
\r\n\r\n\t\r\n
\r\n\r\n \r\n

Meet Lykan’s Board of Directors<\/span><\/h3> \r\n <\/div>\r\n\r\n\r\n\t\r\n<\/div>\r\n <\/div>\r\n\r\n \r\n<\/div>\r\n\n\n<\/a>
\r\n\r\n\t\t\t\t\t\t\r\n
\r\n
\r\n\r\n\t\t\t
\r\n\t